1-bromo-9-fluorononane CAS:926923-52-6

1-bromo-9-fluorononane

Chemical Name:1-bromo-9-fluorononane
CAS.NO:926923-52-6
Synonyms:1-bromo-9-fluorononane
Nonane, 1-bromo-9-fluoro-
Molecular Formula:C8H16BrF
Molecular Weight:211.11500
 
Physical and Chemical Properties:
Density:1.178
Boiling point:224.2ºC
Flash point:92.3ºC
Index of Refraction:1.437
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



We are professional 1-bromo-9-fluorononane manufacturer and Nonane, 1-bromo-9-fluoro- supplier in China, We offer quality 1-bromo-9-fluorononane you can fully trust, also we have India factory and producer of Nonane, 1-bromo-9-fluoro-,Pls send inquiry of Nonane, 1-bromo-9-fluoro- CAS:926923-52-6 to info@nbinno.com if you have any interests, thank you!


Related News: “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.N-(2-Aminoethyl)-3-Aminopropyltriethoxysilane CAS:5089-72-5 Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.2-Methyl-3-nitrobenzotrifluoride CAS:6656-49-1 Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.4-(4-bromophenyl)-N,N-diphenylaniline These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.